Is travel to altitudes of 7,900–10,000 feet contraindicated for a patient with an unrepaired patent foramen ovale (PFO) who has a history of cerebrovascular accident (stroke)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Travel to High Altitude with Unrepaired PFO After Stroke

Travel to altitudes of 7,900–10,000 feet is NOT absolutely contraindicated for your patient with an unrepaired PFO and prior stroke, but requires careful risk assessment and precautions. The altitude range you're asking about (2,400–3,000 meters) falls into a moderate-risk zone that warrants individualized evaluation based on specific PFO characteristics and stroke history.

Risk Assessment Framework

PFO-Specific Factors That Increase Risk

The key issue is that altitude-induced hypoxia can worsen right-to-left shunting through the PFO, potentially increasing paradoxical embolism risk 1, 2. Your patient's risk depends on:

  • Size of the PFO and shunt magnitude: Large PFOs (≥10mm) with substantial right-to-left shunting pose higher risk 2, 3
  • Presence of atrial septal aneurysm: This anatomical variant dramatically increases stroke risk at altitude (OR 15.59) 1
  • Prior stroke mechanism: If the stroke was definitively PFO-related (PASCAL classification "probable"), altitude exposure carries more concern 4

High-altitude exposure increases pulmonary artery pressures through hypoxic pulmonary vasoconstriction 5, which can augment right-to-left shunting across the PFO. Research shows PFO prevalence is 4 times higher in individuals susceptible to high-altitude pulmonary edema (56% vs 11%) 3, and PFO significantly increases acute mountain sickness risk (OR 4.15) 2.

Practical Recommendations

If Travel is Necessary:

Implement these specific precautions:

  • Ascent profile: Gradual ascent is critical—do not exceed 300-500 meters per day above 2,500 meters 5. For your patient going to 7,900-10,000 feet, this means spending at least 1-2 days acclimatizing at intermediate altitude before reaching the destination
  • Antiplatelet therapy: Ensure strict adherence to prescribed antiplatelet medication (typically aspirin or clopidogrel) 6
  • Hydration: Maintain excellent hydration to counteract hypoxic diuresis and reduce thrombotic risk 5
  • Activity limitation: Avoid strenuous physical exertion, especially in the first 3-5 days at altitude 7
  • Prophylactic acetazolamide: Consider 125-250mg twice daily starting 1-2 days before ascent to facilitate acclimatization 8

Contraindications to Travel:

Do NOT travel to this altitude if:

  • The patient has had recent stroke (within 6 weeks) or unstable neurological status 9
  • The PFO is very large with documented massive shunt and associated atrial septal aneurysm 1, 3
  • There are multiple recurrent strokes despite medical therapy 1
  • The patient has concurrent right-sided heart disease or pulmonary hypertension, which would worsen right-to-left shunting 1

Why PFO Closure Wasn't Done

The guideline evidence shows insufficient data to routinely recommend PFO closure even after cryptogenic stroke (Class IIb, Level C) 1. The decision reflects uncertainty about paradoxical embolism diagnosis and concerns about device-related atrial fibrillation (1.8% absolute increase) 1, 6. However, recent data from the PASCAL classification system suggests patients with "probable" PFO-related strokes benefit from closure (2.5% absolute stroke reduction vs 1.3% AF increase) 4.

Clinical Caveats

Important considerations:

  • Commercial air travel to this destination is generally safe since cabin pressure is maintained at equivalent altitude of ~8,000 feet 9, 8, similar to your destination altitude
  • The first 3-5 days carry highest risk due to incomplete acclimatization and peak sympathetic activation 5, 7
  • Decompression sickness risk: The guideline specifically mentions that high-altitude aviators with PFO and multiple recurrences may warrant closure 1, suggesting recognized risk in this population
  • Monitoring: Watch for symptoms of acute mountain sickness (headache, nausea, dizziness, fatigue) or neurological changes 2, 10

Bottom Line

For a stable patient with controlled risk factors, brief travel to 7,900-10,000 feet with proper precautions is reasonable. However, if the patient has a large PFO with atrial septal aneurysm and the prior stroke was clearly PFO-related, strongly consider PFO closure before any high-altitude travel 4. For prolonged stays or higher altitudes (>3,500 meters), the risk-benefit calculation shifts unfavorably without closure 5, 7.

References

Research

Relation of Patent Foramen Ovale to Acute Mountain Sickness.

The American journal of cardiology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.